Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance.

Welch, Brett D; Francis, J Nicholas; Redman, Joseph S; Paul, Suparna; Weinstock, Matthew T; Reeves, Jacqueline D; Lie, Yolanda S; Whitby, Frank G; Eckert, Debra M; Hill, Christopher P; Root, Michael J; Kay, Michael S

The HIV gp41 N-trimer pocket region is an ideal viral target because it is extracellular, highly conserved, and essential for viral entry. Here, we report on the design of a pocket-specific D-peptide, PIE12-trimer, that is extraordinarily elusive to resistance and characterize its inhibitory and structural properties. D-peptides (peptides composed of D-amino acids) are promising therapeutic agents due to their insensitivity to protease degradation. PIE12-trimer was designed using structure-guided mirror-image phage display and linker optimization and is the first D-peptide HIV entry inhibitor with the breadth and potency required for clinical use. PIE12-trimer has an ultrahigh affinity for the gp41 pocket, providing it with a reserve of binding energy (resistance capacitor) that yields a dramatically improved resistance profile compared to those of other fusion inhibitors. These results demonstrate that the gp41 pocket is an ideal drug target and establish PIE12-trimer as a leading anti-HIV antiviral candidate.